Nu Skin Enterprises, Inc. Class A (NUS)

Nu Skin's third-quarter 2025 results were reported on November 6, 2025, with revenue and EPS within guidance, and second-quarter results on August 7, 2025, exceeded earnings expectations. Quarterly cash dividends of $0.06 per share were declared on August 7, 2025, and November 6, 2025. Nu Skin was ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. The company is preparing for the introduction of its Prysm iO intelligent wellness platform and began pre-market opening activities in India. Analyst ratings have varied, with downgrades from Zacks Research and Wall Street Zen. The stock's 52-week range has been between $5.32 and $14.62, and as of January 12, 2026, the stock price was around $10.45.

Demand for Nu Skin's products exhibits seasonality, with the first quarter typically being the lowest. The company anticipates continued economic challenges and poor consumer sentiment, particularly in Greater China and South Korea, which could affect demand. New products and platforms, such as the Prysm iO, are expected to stimulate growth.

Nu Skin Enterprises, Inc., founded in 1984, is a global direct-selling company focused on beauty and wellness solutions. It operates in the health and wellness and beauty industries, with its primary industry being Personal Products, and also includes Food Products. Key brands include Nu Skin®, Pharmanex®, and ageLOC®. The company offers skincare devices, cosmetics, and nutritional supplements and is innovating with the Prysm iO intelligent wellness platform.

Nu Skin distributes its products in over 50 markets across the Americas, Europe, Africa, and Asia. It operates through geographic segments including Mainland China, South Korea, Southeast Asia/Pacific, Americas, Japan, Hong Kong/Taiwan, and Europe, Middle East and Africa.

Nu Skin's brand reputation has been positively impacted by its recognition as the world's No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. The company emphasizes scientific innovation, product efficacy, and a mission to be a "force for good worldwide," focusing on products backed by scientific research.

Institutional investors hold a significant portion of Nu Skin's stock, approximately 49.80% to 61.67%. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and Charles Schwab Investment Management Inc. Insiders own approximately 3.33% of the company's stock, while public companies and individual investors hold around 46.87%.